Want your therapy to make it to patients first? Partner with a CRO who anticipates your needs with delivery of fast, flexible service and a proven ability to take therapies from
discovery to market. Charles River has guided clients to success with a record of 52 patents and 17 candidates, and work on 80% of oncology therapies approved in 2017.
Find out what we can do for you at www.criver.com/oncology.